%D8%A3%D9%88%D8%B3%D9%8A%D9%84%D8%AA%D8%A7%D9%85%D9%8A%D9%81%D9%8A%D8%B1%D8%A7%D9%88%D8%B3%D9%84%D8%AA%D8%A7%D9%85%DB%8C%D9%88%DB%8C%D8%B1%E0%BD%A8%E0%BD%BC%E0%BC%8B%E0%BD%A6%E0%BD%BA%E0%BD%A3%E0%BC%8B%E0%BD%8F%E0%BD%B1%E0%BC%8B%E0%BD%98%E0%BD%B2%E0%BC%8B%E0%BD%9D%E0%BD%B2%E0%BD%A2%E0%BC%8DOseltamivirOseltamivirTamifluOseltamivirCategory:OseltamivirOseltamivirOseltamiviroOseltamivir%D8%A7%D8%B3%D9%84%D8%AA%D8%A7%D9%85%DB%8C%D9%88%DB%8C%D8%B1OseltamiviiriOseltamivirOseltamivirOszeltamivir%D5%95%D5%BD%D5%A5%D5%AC%D5%BF%D5%A1%D5%B4%D5%AB%D5%BE%D5%AB%D6%80OseltamivirOseltamivir%E3%82%AA%E3%82%BB%E3%83%AB%E3%82%BF%E3%83%9F%E3%83%93%E3%83%AB%EC%98%A4%EC%85%80%ED%83%80%EB%AF%B8%EB%B9%84%EB%A5%B4Oseltamivirum%D0%9E%D1%81%D0%B5%D0%BB%D1%82%D0%B0%D0%BC%D0%B8%D0%B2%D0%B8%D1%80OseltamivirOseltamivirOseltamivirOseltamivir%E0%AC%93%E0%AC%B8%E0%AD%87%E0%AC%B2%E0%AC%9F%E0%AC%BE%E0%AC%AE%E0%AC%BF%E0%AC%AD%E0%AC%BF%E0%AC%B0OseltamiwirOseltamivirOseltamivir%D0%9E%D1%81%D0%B5%D0%BB%D1%8C%D1%82%D0%B0%D0%BC%D0%B8%D0%B2%D0%B8%D1%80OseltamivirOseltamivirTamifluOseltamivirOseltamivir%E0%B9%82%E0%B8%AD%E0%B9%80%E0%B8%8B%E0%B8%A5%E0%B8%97%E0%B8%B2%E0%B8%A1%E0%B8%B4%E0%B9%80%E0%B8%A7%E0%B8%B5%E0%B8%A2%E0%B8%A3%E0%B9%8C%D0%9E%D0%B7%D0%B5%D0%BB%D1%8C%D1%82%D0%B0%D0%BC%D1%96%D0%B2%D1%96%D1%80Oseltamivir
about
P1056
Alcohol Inhibits Drug Metabolism by CarboxylesterasesEffect of Early Antiviral Therapy on Duration of Cough in Flu PatientsEvaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening InfluenzaSafety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With AmantadineTime to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)A Multicenter Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITP With High Platelet Desialylation LevelTCAD vs. Monotherapy for Influenza A in Immunocompromised PatientsFlufenamic Acid for Hospitalised Influenza InfectionOseltamivir for Influenza Lower Respiratory Tract Infection in Children Under OneA Single Dose Study of Tamiflu in Volunteers in Dialysis And in Volunteers With Reduced Creatinine ClearanceCharacterisation of the Human Carboxylesterase 1 (CES1) Mutations in ThailandEvaluating the Use of Oseltamivir for the Treatment of Influenza in AdultsA Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With InfluenzaStudy to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like SymptomsProof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune ThrombocytopeniaA Pharmacokinetics Study of Favipiravir in Patients With Severe InfluenzaEvaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat InfluenzaAdjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of InfluenzaIntravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and PneumoniaProphylactic Treatment With OseltamivirSevere Influenza Trial of ARbidolOseltamivir Versus Paracetamol for Influenza-like Illness During the Influenza SeasonStudy to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe InfluenzaComparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for ComplicationsA Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy VolunteersEffect of Oseltamivir on Cognitive Function in Subjects With InfluenzaRapid Empiric Treatment With Oseltamivir Study (RETOS)Pharmacokinetics of Oseltamivir Carboxylate In Morbidly Obese SubjectsInterferon Alpha Lozenges Plus Oseltamivir for Influenza TreatmentA Pharmacokinetic Study on Co-administration of Tamiflu (Oseltamivir) and Rimantadine in Healthy VolunteersSafety and Efficacy of Oseltamivir in Children Younger Than One Year of AgeObservational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During LactationA Study of Intravenous Tamiflu (Oseltamivir) in Children With InfluenzaA Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu StrainOseltamivir Randomised Controlled Efficacy TrialEvaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like SymptomsStudy of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza ComplicationsA Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge ModelA Study to Assess the Drug-Drug Interaction Between VX-787 and OseltamivirBanlangen Granules Anti-seasonal Influenza Study
P4844
Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virusDetection of the antiviral drug oseltamivir in aquatic environmentsOral oseltamivir in human experimental influenza B infection.Pharmacokinetics and tolerability of oseltamivir combined with probenecid.Oseltamivir.Oseltamivir: a review of its use in influenza.Oseltamivir: a clinical and pharmacological perspective.Study of oseltamivir and zanamivir resistance-related mutations in influenza viruses isolated from wild mallards in SwedenOseltamivir (tamiflu) is a substrate of peptide transporter 1.Desorption electrospray ionization reactions between host crown ethers and the influenza neuraminidase inhibitor oseltamivir for the rapid screening of Tamiflu.[Oseltamivir resistant avian influenza unsettling. Private hoarding of influenza agents a potential threat against public health].Oseltamivir for treatment and prophylaxis of influenza infectionCombination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza VirusReplacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South AfricaNeuropsychiatric events in an adult patient with influenza a (H3N2) treated with oseltamivir (Tamiflu): a case reportReduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, CanadaDifferent Regimens in Influenza Postexposure Chemoprophylaxis in Children
P921
description
antiviral medication
@en
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Oseltamiviiri
@fi
Oseltamivir
@cs
Oseltamivir
@de
Oseltamivir
@es
Oseltamivir
@id
Oseltamivir
@it
Oseltamivir
@nan
Oseltamivir
@nb
Oseltamivir
@nl
Oseltamivir
@oc
type
label
Oseltamiviiri
@fi
Oseltamivir
@cs
Oseltamivir
@de
Oseltamivir
@es
Oseltamivir
@id
Oseltamivir
@it
Oseltamivir
@nan
Oseltamivir
@nb
Oseltamivir
@nl
Oseltamivir
@oc
altLabel
(-)-oseltamivir
@en
(3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid
@en
(3R,4R,5S)-4-乙醘氨基-5-氨基-3(1-乙基丙氧基)-1-環己烯-1-羧酸乙酯
@zh
(−)-oseltamivir
@en
1-Cyclohexene-1-carboxylic aci ...... r, (3R-(3alpha,4beta,5alpha))-
@en
196618-13-0
@fr
4-Acetylamido-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid
@en
C16H28N2O4
@fr
C16H28N2O4
@it
C16H28N2O4
@ja
prefLabel
Oseltamiviiri
@fi
Oseltamivir
@cs
Oseltamivir
@de
Oseltamivir
@es
Oseltamivir
@id
Oseltamivir
@it
Oseltamivir
@nan
Oseltamivir
@nb
Oseltamivir
@nl
Oseltamivir
@oc